Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger and BTB domain-containing protein 7C (ZBTB7C) is a nuclear transcription factor characterized by a C2H2-type zinc finger motif that binds specific DNA sequences and a BTB/POZ domain that mediates protein-protein interactions and chromatin remodeling. It regulates gene expression by acting as both a transcriptional repressor and activator, influencing processes such as cell cycle progression, cell differentiation, and metabolism—including glucose, glutamine, and lipid metabolic pathways. In cancer biology, ZBTB7C displays context-dependent roles—functioning as a tumor suppressor (notably in colorectal cancer, where low expression correlates with poor survival) or as a proto-oncogene (promoting proliferation and metabolic reprogramming in certain tumor types, including renal cancer and osteosarcoma). ZBTB7C also interacts physically with p53, repressing expression of key target genes involved in cell cycle arrest and apoptosis. Its expression and function have broader implications in neurodegenerative diseases (e.g., sex-specific associations with Alzheimer’s disease) and metabolic disorders. While considered a potential therapeutic target and biomarker, there are no known direct small molecule modulators or drugs currently targeting ZBTB7C in clinical use
Transcriptional regulation—repression of target genes (such as p21/CDKN1A and SIRT1) via interaction with p53 and chromatin-modifying complexes; Modulation of metabolic enzymes (e.g., transcriptional activation of glutaminase for glutamine metabolism, fatty acid synthase for lipid synthesis)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger and BTB domain-containing protein 7C (ZBTB7C).